Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Condition: Meniere Disease Interventions: Drug: OTO-104; Drug: Placebo Sponsor: Otonomy, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2018 Category: Research Source Type: clinical trials